The Executive Committee comprises the following permanent members.
Paul Hudson
Chief Executive Officer
Term expires 2026
Houman Ashrafian
Executive Vice President, Head of Research and Development
Natalie Bickford
Executive Vice President, Chief People Officer
Olivier Charmeil
Executive Vice President, General Medicines
Audrey Duval
Executive Vice President, Corporate Affairs
Brian Foard
Executive Vice President, Head of Specialty Care
Emmanuel Frenehard
Executive Vice President, Chief Digital Officer
Brendan O’Callaghan
Executive Vice President, Manufacturing and Supply
Roy Papatheodorou
Executive Vice President, General Counsel
Madeleine Roach
Executive Vice President, Business Operations
François-Xavier Roger
Executive Vice President, Chief Financial Officer
Thomas Triomphe
Executive Vice President, Vaccines
Julie Van Ongevalle
President and Chief Executive Officer, Opella